Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/9068
Title: Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens
Authors: Arsenijevic A.
Milovanovic, Marija
Milovanovic, Jelena
Stojanovic B.
Zdravković N.
Leung P.
LIU F.
Gershwin M.
Lukic, Miodrag
Issue Date: 2016
Abstract: Galectin-3 (Gal-3) is a carbohydrate binding lectin, with multiple roles in inflammatory diseases and autoimmunity including its antiapoptotic effect on epithelial cells. In particular, increased expression of Gal-3 in epithelial cells is protective from apoptosis. Based on the thesis that apoptosis of biliary epithelial cells (BECs) is critical to the pathogenesis of Primary Biliary Cholangitis (PBC), we have analyzed the role of Gal-3 in the murine model of autoimmune cholangitis. We took advantage of Gal-3 knockout mice and immunized them with a mimotope of the major mitochondrial autoantigen of PBC, 2-octynoic acid (2-OA) coupled to BSA (2OA-BSA) and evaluated the natural history of subsequent disease, compared to control wild-type mice, by measuring levels of antibodies to PDC-E2, immunohistology of liver, and expression of Gal-3. We report herein that deletion of Gal-3 significantly exacerbates autoimmune cholangitis in these mice. This is manifested by increased periportal infiltrations, bile duct damage, granulomas and fibrosis. Interestingly, the BECs of Gal-3 knockout mice had a higher response to apoptotic stimuli and there were more pro-inflammatory lymphocytes and dendritic cells (DCs) in the livers of Gal-3 knockout mice. In conclusion, Gal-3 plays a protective role in the pathways that lead to the inflammatory destruction of biliary epithelial cells.
URI: https://scidar.kg.ac.rs/handle/123456789/9068
Type: article
DOI: 10.1038/srep23348
SCOPUS: 2-s2.0-84961822851
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

146

Downloads(s)

15

Files in This Item:
File Description SizeFormat 
10.1038-srep23348.pdf7.57 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons